Global Sleep Hypoventilation Market Forecast, Trend Analysis And Competition Tracking - Global Market insights 2015 to 2031

Sleep Hypoventilation Market Introduction:

Sleep Hypoventilation Market: Sleep-related hypoventilation is a type of respiratory depression that affects healthy normal sleep. It occurs in any age groups including babies and young people. Hypoventilation disorders occur with improper functioning of the nervous system that leads to low levels of oxygen and an increased level of carbon dioxide in the blood. In addition, it is caused by obstructions in the lower airway, abnormal functioning of lungs, heart, muscles, and nerves. For a normal person, the brain, nerves, and muscles work together to regulate breathing during sleep but for the person with a sleep disorder, this system shows abnormal behavior. Sleep-related hypoventilation occurs independently or, more commonly, with other medical or neurological disorders or long term use of opioids or benzodiazepines.

Request Covid - 19 Impact

Sleep hypoventilation disorder is of three subtypes, such as idiopathic hypoventilation, congenital central alveolar hypoventilation, and comorbid sleep-related hypoventilation. The most common symptoms seen in hypoventilation include daytime sleepiness, morning headaches, frequent awakenings during sleep, stomach problems, insomnia, faintness, difficulty breathing, and reduced exercise capacity. A significant rise in sleep-related hypoventilation may lead to heart failure, brain and blood disorders, and respiratory failure. Hypoventilation can be treated with some therapeutic and diagnostic devices. Therapeutic devices include PAP devices, oral devices, nasal devices, chin straps, and diagnostic devices includes actigraphs, polysomnography, respiratory polygraphs, pulse oximeters, and others. The most widely used process to treat sleep hypoventilation is the Continuous Positive Airway Pressure(CPAP) and Polysomnography . Certain air pressure devices are also used to adjust the pressure that helps to keep the airways open while a person is sleeping. There are also oral applications for patients who have difficulty in using pressure adjustment devices. Whereas, Polysomnography records brain waves, heart rate and breathing, and the oxygen level in the blood.

Positive impact on the market revenue growth

Growing popularity and the availability of high-calorie foods among youths may lead to obesity. This in turn, gives rise to various ailments like a sleep disorder. This is a crucial factor that is driving the growth of sleep-related hypoventilation diagnostic devices in the market. The use of sleep diagnostic devices will help diagnose the problem at a very early stage. Hence this factor is considered to be one of the primary reasons for the growth of sleep apnea diagnostic devices. Sleep disorder diagnostic devices such as Positive Airway Pressure (PAP) devices have witnessed significant development in terms of design, efficacy, and safety has helped to boost the adoption of product and patient outcome. Moreover, small PAP devices for individual use at home and the availability of cheaper brands are expected to fuel the growth of the sleep disorder devices market over the forecast period.

Restraining fators that limit the market revenue growth to a certain extent

The high cost of diagnostic devices such as CPAP devices may restrain the growth of the target market especially in developing countries. In most developed countries the cost of CPAP devices is provided by medical insurance companies. In addition, the rising disposable income of people plays a decisive role in the growth of the target market.

COVID-19 Impact on Sleep Hypoventilation Market

COVID-19 has put the medical device industry first, with unprecedented demand for certain products such as diagnostic tests, Personal Protective Equipment (PPE) and ventilators. However, not all medical devices are essential for patient management during a pandemic. Due to the dramatic reduction in elective medical procedures, many of them have been postponed or cancelled so that hospitals can focus their resources on treating COVID-19 patients, leading to a reduction in the use of other products.

Sleep Hypoventilation Market Dynamics

Global sleep-related hypoventilation market is segregated into type, end-user, and region. The type segment includes therapeutic devices and diagnostic devices. The therapeutic devices segment is expected to register a significant market share in terms of revenue and also maintain its dominance during the forecast period. This attributed to the rise in awareness and use of therapeutic devices for patient medication treatment in developed countries such as, US, Canada and others. Based on the region, North America is estimated to dominate the target market owing to the growing sleep disorders and increasing awareness among people for early diagnosis and detection. Besides, North America is considered one of the most sleep-deprived people in the world.

Global Sleep-related Hypoventilation Market Segmentation:

Based on the Type:

• Therapeutic Devices
• PAP Devices
• Oral Devices
• Nasal Devices
• Chin Straps
• Diagnostic Devices
• Actigraphs
• Polysomnography
• Respiratory Polygraphs
• Pulse Oximeters

Based on the End-User:

• Sleep Laboratories and Hospitals
• Home Care Settings/Individuals

Key Players in the market are:

• BMC Medical Co. Ltd.
• GE Healthcare
• Fisher & Paykel Healthcare Limited
• Curative Medical Inc.
• Cadwell Laboratories
• ResMed
• Invacare Corporation
• Braebon Medical Corporation
• ImThera Medical Inc.
• Phillips Respironics
• Curative Medical Inc.
• Nihon Kohden
• Compumedics Limited
• Other Key Industry Players

Research Scope:

Forecast Period: 2022-2031

Actual Year: 2021

Historical Data Available for: 2015-2020

Key Regions Covered

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Peru
  • Rest of South America
• Middle East & Africa
  • GCC
  • South Africa
  • Israel
  • Rest of MEA

• BMC Medical Co. Ltd.
• GE Healthcare
• Fisher & Paykel Healthcare Limited
• Curative Medical Inc.
• Cadwell Laboratories
• ResMed
• Invacare Corporation
• Braebon Medical Corporation
• ImThera Medical Inc.
• Phillips Respironics
• Curative Medical Inc.
• Nihon Kohden
• Compumedics Limited
• Other Key Industry Players